Scarica l'app Stockscreener
60.49
3.31%
1.94
Dopo l'orario di chiusura:
60.40
-0.09
-0.15%
Precedente Chiudi:
$58.55
Aprire:
$58.55
Volume 24 ore:
3.33M
Relative Volume:
2.99
Capitalizzazione di mercato:
$4.83B
Reddito:
$541.74M
Utile/perdita netta:
$88.01M
Rapporto P/E:
55.69
EPS:
1.0862
Flusso di cassa netto:
$155.34M
1 W Prestazione:
+12.79%
1M Prestazione:
+36.82%
6M Prestazione:
+42.36%
1 anno Prestazione:
+125.62%
Intervallo 1D:
$58.06
$60.83
Intervallo di 1 settimana:
$52.36
$60.83
Portata 52W:
$22.61
$60.83
Veracyte Inc Stock (VCYT) Company Profile
Nome
Veracyte Inc
Settore
Industria
Telefono
(650) 243-6300
Indirizzo
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
60.49 | 4.67B | 541.74M | 88.01M | 155.34M | 1.0862 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Iniziato | Jefferies | Buy |
| 2025-12-02 | Ripresa | Morgan Stanley | Underweight |
| 2025-10-20 | Iniziato | Canaccord Genuity | Hold |
| 2025-03-20 | Iniziato | Craig Hallum | Buy |
| 2024-12-05 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-10-16 | Iniziato | UBS | Buy |
| 2024-10-10 | Iniziato | Guggenheim | Buy |
| 2024-02-23 | Reiterato | Needham | Buy |
| 2023-01-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-11-18 | Ripresa | Goldman | Buy |
| 2021-06-15 | Iniziato | Raymond James | Outperform |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Iniziato | Morgan Stanley | Underweight |
| 2019-07-31 | Iniziato | Lake Street | Buy |
| 2019-07-02 | Iniziato | Needham | Buy |
| 2018-11-29 | Downgrade | Janney | Buy → Neutral |
| 2018-10-31 | Aggiornamento | Janney | Neutral → Buy |
| 2017-11-07 | Downgrade | Janney | Buy → Neutral |
| 2017-11-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Ripresa | BTIG Research | Buy |
| 2016-11-14 | Ripresa | Leerink Partners | Outperform |
| 2015-12-18 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-06-11 | Reiterato | Leerink Partners | Outperform |
| 2013-11-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Veracyte Inc Borsa (VCYT) Ultime notizie
Veracyte, Inc. Actuals & Estimates (TRADEGATE:12V) - TradingView
Veracyte, Inc. Actuals & Estimates (MUN:12V) - TradingView
Veracyte, Inc. Actuals & Estimates (DUS:12V) - TradingView
Q1 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q4 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q2 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q3 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Veracyte, Inc. Actuals & Estimates (NASDAQ:VCYT) - TradingView
Veracyte Inc (VCYT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
VCYT Forecast — Price Target — Prediction for 2027 - TradingView
12V Forecast — Price Target — Prediction for 2027 - TradingView
Veracyte Inc (VCYT) Shares Surge 3.1% -- What GF Score of 75 Tel - GuruFocus
Veracyte Jumps 7.2% Amid Sector-Wide Rally - AlphaStreet
Veracyte stock hits 52-week high at 55.32 USD - Investing.com
Veracyte stock hits 52-week high at 55.32 USD By Investing.com - Investing.com Canada
Insider Sell Alert: Karin Eastham Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Form 4 Veracyte Inc For: 22 June By Investing.com - Investing.com South Africa
Veracyte director Karin Eastham sells $197,234 in stock By Investing.com - Investing.com South Africa
Veracyte director Karin Eastham sells $197,234 in stock - Investing.com
Veracyte (VCYT) director logs 3,729-share Rule 10b5-1 stock sale - Stock Titan
VCYT News | VERACYTE INC (NASDAQ:VCYT) - ChartMill
[144] VERACYTE, INC. SEC Filing - Stock Titan
VCYT|Veracyte Inc|Price:53.630|Chg%:2.34 - TradingKey
Veracyte Inc (VCYT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Veracyte Inc (VCYT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Veracyte Inc (VCYT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Veracyte Inc (VCYT) Institutional Confidence - TradingKey
Veracyte Inc (VCYT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Veracyte Inc (VCYT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Veracyte stock hits 52-week high at 50.81 USD By Investing.com - Investing.com South Africa
Is Veracyte Inc (VCYT) Overvalued After 3.5% Rally? GF Value Say - GuruFocus
Veracyte stock hits 52-week high at 50.81 USD - Investing.com
High Growth Momentum Breakout Setup: Veracyte Inc (NASDAQ:VCYT) - ChartMill
Veracyte (VCYT) director Jens Holstein awarded 5,272 restricted stock units - Stock Titan
Veracyte (VCYT) director Eliav Barr receives 5,272 restricted stock units - Stock Titan
Director at Veracyte (VCYT) receives grant of 5,272 restricted stock units - Stock Titan
Evan Jones of Veracyte (NASDAQ: VCYT) receives 5,272 restricted stock units - Stock Titan
Director at VERACYTE, INC. (VCYT) awarded 5,272 restricted stock units - Stock Titan
Veracyte (VCYT) director Robert Epstein receives 5,272-share RSU grant - Stock Titan
[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan
Veracyte (VCYT) director awarded 5,272 RSUs vesting over one year - Stock Titan
Veracyte, Inc. 2023 Equity Incentive Plan Amended – SEC 8-K Filing Details and Company Information - Minichart
Veracyte shareholders endorse board, pay and incentive plans - The Globe and Mail
FMR LLC's Strategic Acquisition of Veracyte Inc Shares - GuruFocus
Veracyte (VCYT) investors back 3.5M-share equity plan increase and elect full board - Stock Titan
Veracyte (NASDAQ:VCYT) Hits New 12-Month HighHere's Why - MarketBeat
Why Veracyte (VCYT) is a top momentum stock for the long term - MSN
Here's why Veracyte (VCYT) is a strong growth stock - MSN
Assessing Veracyte (VCYT) Valuation After New Prosigna Launch And Decipher Prostate Clinical Milestones - Sahm
Veracyte Inc Azioni (VCYT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.76%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):